AL
BAX icon

Aspiriant LLC’s Baxter International BAX Stock Holding History

Aspiriant LLC’s Portfolio BAX Stock Details BAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,717
Closed -$210K – 226
2018
Q3 		$210K Sell
2,717
-597
-18% -$44.3K 0.02% 221
2018
Q2 		$245K Buy
+3,314
New +$234K 0.02% 223
2016
Q3 		– Sell
-12,965
Closed -$869K – 185
2016
Q2 		$869K Buy
+12,965
New +$569K 0.08% 111

Other funds holding BAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Aspiriant LLC's BAX Position: Q4 2018 in Review

Aspiriant LLC sold out of Baxter International (BAX) in Q4 2018, closing a stake of 2,717 shares — an estimated $210K sold.

Aspiriant LLC first reported a position in BAX in Q2 2016 and held it in 3 quarters. The position peaked at $869K in Q2 2016. 1,052 funds tracked by Wall St. Rank hold BAX as of Q4 2018.

  • Aspiriant LLC reported no remaining Baxter International position as of Q4 2018 after selling out during the quarter.
  • Aspiriant LLC sold 2,717 Baxter International shares in Q4 2018, an estimated $210K.
  • Aspiriant LLC first reported a position in Baxter International in Q2 2016 and held it in 3 quarters.
  • Aspiriant LLC's Baxter International position peaked at $869K in Q2 2016.
  • 1,052 funds tracked by Wall St. Rank held Baxter International as of Q4 2018.

Based on Aspiriant LLC's 13F filing for Q4 2018, filed 4 Feb 2019.